Publications
Abstracts and Presentations (1104 POSTS)
2023 (68 POSTS)
Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH).
Mitchell ME, Bylsma LC, Shara NM, Fernandez SJ, Catlett JP, Lai JS, Dong K, Fryzek JP, Daver N, Allen C, Broome CM. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Poster presented at the International Society for Pharmacoepidemiology annual meeting, Poster 166, Halifax, Nova Scotia, August 2023.
Point of care analysis for men with adrenomyeloneuropathy: A retrospective study of real world data
Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr PL, Sawyer EK, Stephen CD, Eichler F. Point of care analysis for men with adrenomyeloneuropathy: A retrospective study of real world data. Poster presentation, European Academy of Neurology, Budapest, Hungary, July 2023.
My paper was not accepted, what did I do wrong? Submitting wisely for publication
Lockwood CM, Price C. My paper was not accepted, what did I do wrong? Submitting wisely for publication. Winter Program of the University of São Paulo, Brazil School of Nursing; https://www.youtube.com/live/GIJM422jY_M?feature=share&t=3052, July 2023.
Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies
Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen CD, Eichler F. Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies. Poster presentation, American Society of Cell and Gene Therapy Meeting, Los Angeles, CA, May 2023.
Health disparities among patients with schizophrenia in an integrated healthcare system.
Seo S, Healey B, McLin R, Sacks N, Benson C, Citrome L. Health disparities among patients with schizophrenia in an integrated healthcare system. Poster presentation, Psych Congress Elevate 2023, May 30-June 2, 2023.
Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome
Jensen I, Srivastava K, Minshall M, Kemp R. Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome. Abstract EE539, ISPOR 2023.
View AbstractWater contaminants in the Portland Harbor: Addressing community concerns related to chemicals and toxicity
Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Water contaminants in the Portland Harbor: Addressing community concerns related to chemicals and toxicity. Seminar presentation at Environmental and Molecular Toxicology Seminar Series, Corvallis, OR, 2023.
Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants
Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants. Oral presentation at Pacific Northwest (PNW) SETAC Annual Conference, Troutdale, OR, 2023.
Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants
Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants. Poster presentation at PANWAT Annual Conference, Portland, OR, 2023.
Suspects and nontarget chemical analyses to address community concerns related to chemicals and toxicity in the Portland harbor
Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Suspects and nontarget chemical analyses to address community concerns related to chemicals and toxicity in the Portland harbor. Poster presentation at SRP Annual Conference, Albuquerque, NM, 2023.
Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD)
Bean K, Miller B, Jensen I, Fields C, Pang F. Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD). Abstract EE285, ISPOR 2023.
View AbstractDirect cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries
Bean K, Olaye A, Miller B, Jensen I, Dean R, Pang F. Direct cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries. Abstract EE408, ISPOR 2023.
View AbstractDisruption of energy homeostasis by PFAS mixtures
Jacobellis M, Bain L, Baldwin W. Disruption of energy homeostasis by PFAS mixtures. Southeastern Society of Toxicology, University of Georgia, Athens, GA, 2023.
Performance micromachining for creation of well plate based microphysiological models
Reynolds JI, Adams M, Johnson BP. Performance micromachining for creation of well plate based microphysiological models. Oral platform at Biomedical Engineering Society Annual Meeting, Seattle, WA, 2023.
Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation
Johnson BP, Reynolds JI. Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation. Society for Birth Defects Research and Prevention 63rd Annual Meeting, Charleston, SC, 2023.
Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH)
Broome CM, Mitchell M, Bylsma L, Shara N, Fernandez S, Catlett J, Lai J, Dong K, Fryzek J, Daver N, Allen C. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Abstract P1202. Poster presented to European Hematology Association-EHA2023, Frankfurt, June 2023.
View AbstractPre-clinical evaluation of cannabidiol toxicity in rats
Lefever TW, Trexler KR, Henderson RG, Bonn-Miller MO. Pre-clinical evaluation of cannabidiol toxicity in rats. Poster at the 32nd Annual International Cannabinoid Research Society Symposium on the Cannabinoids, Galway, Ireland, June 2022.
Prevalence of delta-like ligand 3 expression in small cell lung cancer
Pundole X, Ju C-H, Bylsma LC, Hooda N, Movva N, Elkhouly E, Bebb DG, Fryzek J, et al. 2023. Prevalence of delta-like ligand 3 expression in small cell lung cancer. J Clinical Oncology 41:16_suppl e20618.
View AbstractThe OEHS professional as a proud ally: Recognizing and controlling common occupational hazards impacting LGBTQ+ workers in the U.S.
Ierardi AM, Price S, Parker J. The OEHS professional as a proud ally: Recognizing and controlling common occupational hazards impacting LGBTQ+ workers in the U.S. American Industrial Hygiene Conference & Expo, Phoenix, AZ, 2023.
Overview of global real world data sources for pediatric pharmacoepidemiological research
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, …, Movva N, …, Suh M, et al. Overview of global real world data sources for pediatric pharmacoepidemiological research. Poster 217, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract